CanSino is the seventh China biopharma, and the first vaccine company, to IPO in Hong Kong under its … dosed the first patient in a Phase II Taiwan trial of a CD38 antibody in patients with …
( read original story …)
The Taiwan NEWS
CanSino is the seventh China biopharma, and the first vaccine company, to IPO in Hong Kong under its … dosed the first patient in a Phase II Taiwan trial of a CD38 antibody in patients with …
( read original story …)